They also found that PRC1 combined with immune checkpoint blockade effectively suppresses metastasis in PCa-induced mice, suggesting that CCL2 expression could serve as a biomarker for response to therapy [103]. This evidence concerns the gene PRC1 and posterior cortical atrophy.